Dr M. A. Suboor Shaherose

Dr. M. A. Suboor Shaherose is a Consultant Medical and Hemato-Oncologist with over 12 years of clinical experience. He has advanced training in General Medicine and Medical Oncology, along with European certification in medical oncology. His clinical experience includes cancer treatment, supportive care, pain and palliative care, targeted and immunotherapy, and hematological oncology. He has also been actively involved in oncology research and academic presentations at national and international conferences.

Educational Qualification:

• MBBS – Osmania Medical College (August 2007 – March 2013)
• MD (General Medicine) – Gandhi Medical College (July 2014 – July 2017)
• DrNB (Medical Oncology) – Basavatarakam Indo-American Cancer Hospital and Research Institute (August 2019 – August 2022)
• ECMO – European-Certified Medical Oncologist

Professional Experience:

• Consultant Medical Oncologist and Hemato-Oncologist – CARE Hospitals, Hyderabad, as part of the Kaizen Hematology Oncology Network.
• Consultant Medical Oncologist – Onco Cancer Centres, Hyderabad.
• Consultant Physician – Medisys Hospitals, L.B. Nagar (2018 – June 2019).
• Senior Resident – Department of General Medicine – Government Fever Hospital, Nallakunta (2017 – 2018).
• Resident – General Medicine – Gandhi Medical College (2014 – 2017).
• Intern – Osmania Medical College (2012 – 2013).
• Doctorate of National Board (DrNB) in Medical Oncology – Basavatarakam Indo-American Cancer Hospital and Research Institute (2019 – September 2022).

Awards and Achievements:

• Merit Award – ESMO Asia 2022 for a mini-oral presentation on low-dose versus standard-dose Abiraterone in metastatic castration-resistant prostate cancer.
• Second Prize – APICON 2017 for paper presentation on pleural fluid cholesterol for differentiating exudates from transudates.
• Active participant in national and international oncology conferences and academic presentations.

Professional Memberships:

• European Society of Medical Oncology (ESMO)
• American Society of Clinical Oncology (ASCO)
• Indian Society of Medical and Pediatric Oncology (ISMPO)

Research and Presentations:

• Low-dose Abiraterone vs Standard-dose Abiraterone in Metastatic CRPC – Mini-oral presentation at ESMO Asia 2022.
• Acute Leukemia Presenting as Cerebral Sinus Vein Thrombosis – APICON 2017.
• Pleural Fluid Cholesterol to Differentiate Exudate from Transudate – APICON 2017.
• Cryptococcal Meningitis Presenting with Multiple Cranial Nerve Palsies – State APICON 2016.
• Scleroderma Presenting as Distal Renal Tubular Acidosis – State APICON 2017.
• Concomitant EGFR Mutation and ALK Rearrangement in Patients with NSCLC – ISMPOCON 2020.
• B-cell Non-Hodgkin's Lymphoma in a Patient with Pre-existing Chronic Myeloproliferative Neoplasm – ISMPOCON 2020.
• Treatment and Outcomes of Patients with Primary CNS Lymphoma – IKON 2021.
• Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant at a Tertiary Cancer Centre – ISMPOCON 2022.
• ALK-positive Primary Anaplastic Large Cell Lymphoma of CNS – ISMPOCON 2022.

Publications:

• Acute Copper Sulphate Poisoning: A Case Report – International Journal of Current Medical and Applied Sciences, Vol. 5, Issue 3, February 2015, pp. 178–180.